We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current XBI market cap is 7.56B. The company's latest EPS is USD 9.4734 and P/E is 10.29.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.4M | 14.8M | 35.72M | 11.95M | 18.32M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -539.59M | 1.05B | 1.19B | -3.88B | 733.48M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.7B | 6.26B | 8.09B | 7.44B | 7.08B |
| Total Liabilities | 284.07M | 858.78M | 837.25M | 594.73M | 635.62M |
| Total Equity | 4.41B | 5.4B | 7.25B | 6.84B | 6.45B |
| Market Cap | 7.56B |
| Price to Earnings Ratio | 10.29 |
| Price to Sales Ratio | 411.96 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 77.43M |
| Average Volume (1 week) | 9.76M |
| Average Volume (1 Month) | 8.25M |
| 52 Week Change | 13.48% |
| 52 Week High | 103.52 |
| 52 Week Low | 63.80 |
| Spread (Intraday) | 0.34 (0.35%) |
| Company Name | SPDR S&P Biotech |
| Address |
one iron street boston, massachusetts 02210 |
| Website | https://www.spdrs.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
